BlueCrest Capital Management’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

BlueCrest Capital Management’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-406,422	Closed	-$4.66M	–	386
2021 Q4	$4.66M	Sell	406,422 -3,079,423	-88%	-$34.7M	0.15%	116
2021 Q3	$39.1M	Buy	3,485,845 +785,000	+29%	+$8.75M	1.06%	13
2021 Q2	$30.2M	Buy	2,700,845 +1,630,921	+152%	+$18.3M	0.56%	29
2021 Q1	$12.1M	Buy	+1,069,924	New	+$10.9M	0.2%	110

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

BlueCrest Capital Management's NFH Position: Q1 2022 in Review

BlueCrest Capital Management sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 406,422 shares — an estimated $4.66M sold.

BlueCrest Capital Management first reported a position in NFH in Q1 2021 and held it in 4 quarters. The position peaked at $39.1M in Q3 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

BlueCrest Capital Management reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
BlueCrest Capital Management sold 406,422 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $4.66M.
BlueCrest Capital Management first reported a position in New Frontier Health Corporation Ordinary Shares in Q1 2021 and held it in 4 quarters.
BlueCrest Capital Management's New Frontier Health Corporation Ordinary Shares position peaked at $39.1M in Q3 2021.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on BlueCrest Capital Management's 13F filing for Q1 2022, filed 16 May 2022.